Abstract: This House hearing examines the additional enforcement needed for the requirements of the Federal Food, Drug, and Cosmetic Act. The bill would give the FDA the ability to recall defective and unsafe products, to assess civil penalties, to subpoena witnesses and documents to embargo defective products, and to destroy imported products that pose a danger to public health.

Considers legislation to include certain new antibiotics in Federal drug safety inspection regulations; to require exported drugs, food, cosmetics and devices to comply with domestic product safety standards; and to authorize FDA to charge importers for costs incurred in supervising relabeling and other procedures necessary to bring imported articles into compliance with domestic standards.

The Encyclopedia of Clinical Pharmacy is a valuable resource for today's clinical pharmacist and pharmacotherapist. Over 200 researchers and practitioners provide ready access to more than 5,000 primary literature citations and hard-to-find research on: Gene therapy Health service delivery models Best practices documents Pharmaceutical software development Legal controversies, ethical issues, and court rulings Drug dosing and electronic prescription Post-marketing surveillance Generic equivalency Quality management procedures Educational and training programs Compiling expertise and recommendations from the American College of Clinical Pharmacy and the American Society of Health-System Pharmacists, the Encyclopedia unravels the increasing complexity of pharmacotherapy, the problems of medication-related morbidity and mortality, and the impact that clinically empowered pharmacists have on assuring safe and effective pharmaceutical care for patients.